Evidence map›Paper›PMID 40099827›Full record

ArticleJournal of rehabilitation medicine2025

Trends in spasticity-reducing surgery and botulinum toxin treatment for post-stroke spasticity: a register study on 6,258 patients in Sweden, 2010-2021.

Marcus Sagerfors, Izabela Blaszczyk, Anette Chemnitz, Helena Johansson, Joakim Strömberg

Abstract read
In one paragraph

Article in Journal of rehabilitation medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marcus SagerforsDepartment of Orthopedics and Hand Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. marcus.sagerfors@regionorebrolan.se.ORCID 0000-0002-5083-3591
Izabela BlaszczykDepartment of Diagnostic and Intervention, Hand and Plastic Surgery, Umeå University, Sweden.
Anette ChemnitzHand Center Malmö, Atleva Specialist Care, Sweden.
Helena JohanssonSahlgrenska Osteoporosis Centre, Department of Internal Medicine and Clinical Nutrition, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.ORCID 0000-0002-7720-9297
Joakim StrömbergUniversity of Gothenburg, Sahlgrenska Academy, Institution of Clinical Sciences, Department of Hand Surgery and Department of Surgery and Orthopaedics, Alingsås lasarett, Alingsås, Sweden.ORCID 0000-0001-5252-8710

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spasticity is characterized by increased muscle tone, which can result in pain, contractures, impaired hygiene, and deformities. Stroke is a leading cause of paresis, and nearly 40% of stroke patients will develop spasticity.

objectiveTo assess trends in upper and lower extremity spasticity-reducing surgery and botulinum toxin A (BoNT-A) treatment.

designA national cohort register study.

methodsUpper and lower extremity spasticity-reducing surgery and BoNT-A treatment in Swedish stroke patients over a 12-year period was assessed using the National Patient Register.

resultsA total of 6,258 patients were treated during this period; their mean age was 58, and the majority were male. In both upper and lower extremities, tenotomy was the most common surgical procedure, followed by tendon lengthening. The need for BoNT-A injections was significantly reduced after surgery compared with before surgery. The total number of BoNT-A treatments increased during the study period, and ultrasound guidance of injections became more common.

conclusionThe frequency of BoNT-A treatments was significantly reduced in patients who underwent surgery. Even though no causative association can be established due to the nature of these registry data, this may indicate that surgery reduces the need for further BoNT-A treatments.

Indexed as

Botulinum Toxins, Type AMuscle SpasticityNeuromuscular AgentsStrokeAdultAgedCohort StudiesFemaleHumansLower ExtremityMaleMiddle AgedRegistriesSwedenTenotomyBotulinum Toxins, Type ANeuromuscular Agents

Identifiers

PMID40099827
PMCPMC11971937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.